1-855-378-42281-855-378-4228
One of the out-patient rehab options for individuals in Mineral Point who are battling with opioid abuse and addiction is called opioid maintenance therapy. Licensed centers and doctors are certified to dispense certain medications to opioid dependent people, many of which are opioids themselves and are habit forming. With low amounts however, the user doesn't experience high feelings but also doesn't have acute cravings and isn't experiencing opioid withdrawal. Methadone is the first medication used for this sole purpose, but there are alternative choices currently to select from.
Methadone is an opioid and can be taken at an outpatient medical center certified to dispense the drug, that is taken on a daily basis as a pill or liquid. The price of the med is approximately $150 per month. Buprenorphine is also an opiate based med, and is a pill often taken one day on, one day off. But different from Methadone that can only be dispensed in well-regulated medical centers, Buprenorphine can be prescribed and administered in doctor's offices. The cost monthly of buprenorphine is around just under $300 /month for the generic version of the medication. There is also a version of buprenorphine that contains naloxone, which is a drug that blocks the effects of opiates. An individual consuming this formulation, also known as Suboxone, would find it harder to feel high from opioids if they relapsed while taking the drug. It is also taken daily, and costs approximately $450 per month. Naltrexone is an additional medication taken in opioid maintenance therapy, but unlike the other medications mentioned it is an opiate blocker and isn't an opiate. There is an option to take this drug as a monthly shot, and that is called Vivitrol. As an opioid blocker, the drug prevents someone from getting high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 monthly.
For All Alcohol and Drug Treatment Programs In Mineral Point, Click Here.
